157 related articles for article (PubMed ID: 35307409)
1. Mechanisms underlying melanoma invasion as a consequence of MLK3 loss.
Balinda HU; Sedgwick A; D'Souza-Schorey C
Exp Cell Res; 2022 Jun; 415(1):113106. PubMed ID: 35307409
[TBL] [Abstract][Full Text] [Related]
2. Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.
Zhang H; Wu W; Du Y; Santos SJ; Conrad SE; Watson JT; Grammatikakis N; Gallo KA
J Biol Chem; 2004 May; 279(19):19457-63. PubMed ID: 15001580
[TBL] [Abstract][Full Text] [Related]
3. A novel role for mixed lineage kinase 3 (MLK3) in B-Raf activation and cell proliferation.
Chadee DN; Kyriakis JM
Cell Cycle; 2004 Oct; 3(10):1227-9. PubMed ID: 15467451
[TBL] [Abstract][Full Text] [Related]
4. Osmotic and heat stress-dependent regulation of MLK4β and MLK3 by the CHIP E3 ligase in ovarian cancer cells.
Blessing NA; Kasturirangan S; Zink EM; Schroyer AL; Chadee DN
Cell Signal; 2017 Nov; 39():66-73. PubMed ID: 28757353
[TBL] [Abstract][Full Text] [Related]
5. Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.
Ambrosini G; Pratilas CA; Qin LX; Tadi M; Surriga O; Carvajal RD; Schwartz GK
Clin Cancer Res; 2012 Jul; 18(13):3552-61. PubMed ID: 22550165
[TBL] [Abstract][Full Text] [Related]
6. MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation.
Chadee DN; Kyriakis JM
Nat Cell Biol; 2004 Aug; 6(8):770-6. PubMed ID: 15258589
[TBL] [Abstract][Full Text] [Related]
7. Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein.
Chadee DN; Xu D; Hung G; Andalibi A; Lim DJ; Luo Z; Gutmann DH; Kyriakis JM
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4463-8. PubMed ID: 16537381
[TBL] [Abstract][Full Text] [Related]
8. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
9. The E3 ligase CHIP mediates ubiquitination and degradation of mixed-lineage kinase 3.
Blessing NA; Brockman AL; Chadee DN
Mol Cell Biol; 2014 Aug; 34(16):3132-43. PubMed ID: 24912674
[TBL] [Abstract][Full Text] [Related]
10. 17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.
Joshi SS; Jiang S; Unni E; Goding SR; Fan T; Antony PA; Hornyak TJ
PLoS One; 2018; 13(2):e0191264. PubMed ID: 29481571
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.
Huntington JT; Shields JM; Der CJ; Wyatt CA; Benbow U; Slingluff CL; Brinckerhoff CE
J Biol Chem; 2004 Aug; 279(32):33168-76. PubMed ID: 15184373
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors.
Shen YH; Godlewski J; Zhu J; Sathyanarayana P; Leaner V; Birrer MJ; Rana A; Tzivion G
J Biol Chem; 2003 Jul; 278(29):26715-21. PubMed ID: 12738796
[TBL] [Abstract][Full Text] [Related]
13. Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespib.
Acquaviva J; Smith DL; Jimenez JP; Zhang C; Sequeira M; He S; Sang J; Bates RC; Proia DA
Mol Cancer Ther; 2014 Feb; 13(2):353-63. PubMed ID: 24398428
[TBL] [Abstract][Full Text] [Related]
14. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis.
Chen J; Gallo KA
Cancer Res; 2012 Aug; 72(16):4130-40. PubMed ID: 22700880
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway.
Lin CH; Yu MC; Tung WH; Chen TT; Yu CC; Weng CM; Tsai YJ; Bai KJ; Hong CY; Chien MH; Chen BC
Biochim Biophys Acta; 2013 Dec; 1833(12):2823-2833. PubMed ID: 23906792
[TBL] [Abstract][Full Text] [Related]
16. Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.
Nissan MH; Pratilas CA; Jones AM; Ramirez R; Won H; Liu C; Tiwari S; Kong L; Hanrahan AJ; Yao Z; Merghoub T; Ribas A; Chapman PB; Yaeger R; Taylor BS; Schultz N; Berger MF; Rosen N; Solit DB
Cancer Res; 2014 Apr; 74(8):2340-50. PubMed ID: 24576830
[TBL] [Abstract][Full Text] [Related]
17. Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival.
Das S; Sondarva G; Viswakarma N; Nair RS; Osipo C; Tzivion G; Rana B; Rana A
J Biol Chem; 2015 Aug; 290(35):21705-12. PubMed ID: 26152725
[TBL] [Abstract][Full Text] [Related]
18. MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.
Schroyer AL; Stimes NW; Abi Saab WF; Chadee DN
Oncogene; 2018 Feb; 37(8):1031-1040. PubMed ID: 29084209
[TBL] [Abstract][Full Text] [Related]
19. Mixed lineage kinase 3 is required for matrix metalloproteinase expression and invasion in ovarian cancer cells.
Zhan Y; Abi Saab WF; Modi N; Stewart AM; Liu J; Chadee DN
Exp Cell Res; 2012 Aug; 318(14):1641-8. PubMed ID: 22652451
[TBL] [Abstract][Full Text] [Related]
20. Loss of TRB3 alters dynamics of MLK3-JNK signaling and inhibits cytokine-activated pancreatic beta cell death.
Humphrey RK; Ray A; Gonuguntla S; Hao E; Jhala US
J Biol Chem; 2014 Oct; 289(43):29994-30004. PubMed ID: 25204656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
